316 related articles for article (PubMed ID: 21951405)
21. STEPS toward the right direction.
Sladek JR; Sanberg PR
Cell Transplant; 2009; 18(7):689. PubMed ID: 19796500
[No Abstract] [Full Text] [Related]
22. [Acute stroke treatment - an update].
Röther J; Hamann GF
Fortschr Neurol Psychiatr; 2010 Oct; 78(10):566-71. PubMed ID: 20927688
[TBL] [Abstract][Full Text] [Related]
23. [To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke].
Li YS
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):733-4. PubMed ID: 21092440
[No Abstract] [Full Text] [Related]
24. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
25. Basic and Translational Vascular Research in China: Past, Present, and Future.
Kong W; Du J; Zhu Y; Dong E
Circ Res; 2017 Aug; 121(4):335-337. PubMed ID: 28775012
[No Abstract] [Full Text] [Related]
26. [Major stroke clinical trials in 2006].
Jeng JS
Acta Neurol Taiwan; 2007 Jun; 16(2):111-20. PubMed ID: 17685137
[TBL] [Abstract][Full Text] [Related]
27. Translational research.
Howells DW; Macleod MR
Int J Stroke; 2012 Jul; 7(5):367-8. PubMed ID: 22712735
[No Abstract] [Full Text] [Related]
28. [Stroke: update on therapy].
Baron JC
Med Sci (Paris); 2009 Oct; 25(10):771-2. PubMed ID: 19849967
[No Abstract] [Full Text] [Related]
29. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.
Lees KR
Stroke; 2002 Jan; 33(1):308-9. PubMed ID: 11779930
[No Abstract] [Full Text] [Related]
30. A strategic plan to accelerate development of acute stroke treatments.
Marler JR
Ann N Y Acad Sci; 2012 Sep; 1268():152-6. PubMed ID: 22994235
[TBL] [Abstract][Full Text] [Related]
31. Comment on "Translational applications of flow cytometry in clinical practice".
Monneret G; Venet F
J Immunol; 2012 Aug; 189(3):1099. PubMed ID: 22815377
[No Abstract] [Full Text] [Related]
32. Thrombolysis, fluctuations, trials, and such.
Caplan LR
Arch Neurol; 2008 Aug; 65(8):1017-9. PubMed ID: 18695051
[No Abstract] [Full Text] [Related]
33. The past and future of neuroprotection in cerebral ischaemic stroke.
Shuaib A; Hussain MS
Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotection in acute ischemic stroke.
De Keyser J; Uyttenboogaart M; Koch MW; Elting JW; Sulter G; Vroomen PC; Luijckx GJ
Acta Neurol Belg; 2005 Sep; 105(3):144-8. PubMed ID: 16255152
[TBL] [Abstract][Full Text] [Related]
35. It covers a broad spectrum of clinical and basic neuroscience.
van Rensburg SJ; Russell V
Metab Brain Dis; 2012 Sep; 27(3):237. PubMed ID: 22648763
[No Abstract] [Full Text] [Related]
36. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotection: establishing proof of concept in human stroke.
Davis SM; Donnan GA
Stroke; 2002 Jan; 33(1):309-10. PubMed ID: 11779931
[No Abstract] [Full Text] [Related]
38. Endovascular stroke trials: why we must enroll all eligible patients.
Goyal M; Shamy M; Menon BK; Saver JL; Diener HC; Mocco J; Pereira VM; Jovin TG; Zaidat O; Levy EI; Davalos A; Demchuk A; Hill MD
Stroke; 2013 Dec; 44(12):3591-5. PubMed ID: 24222044
[No Abstract] [Full Text] [Related]
39. Translational Stroke Research Opportunities and a Strategy to Develop Effective Cytoprotection.
Lapchak PA
Transl Stroke Res; 2017 Aug; 8(4):318-321. PubMed ID: 28271393
[No Abstract] [Full Text] [Related]
40. Advances in stroke neuroprotection: hyperoxia and beyond.
Singhal AB; Lo EH; Dalkara T; Moskowitz MA
Neuroimaging Clin N Am; 2005 Aug; 15(3):697-720, xii-xiii. PubMed ID: 16360598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
